Ana V. Arias

Majadahonda, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Reassessment After Locoregional Treatment of Hepatocellular Carcinoma Previous Liver Transplantation: Is MRI Necessary for All Patients?

Reassessment After Locoregional Treatment of Hepatocellular Carcinoma Previous Liver Transplantation: Is MRI Necessary for All Patients?

Journal: Transplantation proceedings
Published: July 17, 2023

Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors.

Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors.

Journal: Journal of hepatology
Published: May 18, 2023

Transfusion-associated adverse events incidence and severity after the implementation of an active hemovigilance program with 24 h follow-up. A prospective cohort study.

Transfusion-associated adverse events incidence and severity after the implementation of an active hemovigilance program with 24 h follow-up. A prospective cohort study.

Journal: Transfusion
Published: December 13, 2022

Coronavirus Disease 2019 (COVID-19) in Solid Organ Transplant Recipients: A Case-Control Study.

Coronavirus Disease 2019 (COVID-19) in Solid Organ Transplant Recipients: A Case-Control Study.

Journal: Annals of transplantation
Published: November 12, 2021

Indication for Liver Transplantation After Direct-Acting Agents in the Treatment of Patients With Hepatitis C.

Indication for Liver Transplantation After Direct-Acting Agents in the Treatment of Patients With Hepatitis C.

Journal: Transplantation proceedings
Published: August 04, 2021

Major determinants of death in patients hospitalized with COVID-19 during the first epidemic wave in Madrid, Spain.

Major determinants of death in patients hospitalized with COVID-19 during the first epidemic wave in Madrid, Spain.

Journal: Medicine
Published: September 25, 2020

Benefits of hepatitis C cure with antivirals: why test and treat?

Benefits of hepatitis C cure with antivirals: why test and treat?

Journal: Future microbiology
Published: March 23, 2019

Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection.

Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection.

Journal: AIDS (London, England)
Published: August 11, 2018

Delayed laparoscopic cholecystectomy in a case of acute cholecystitis and intestinal malrotation type I.

Delayed laparoscopic cholecystectomy in a case of acute cholecystitis and intestinal malrotation type I.

Journal: Clinics and practice
Published: June 14, 2018

Treatment and prevention of HIV infection with long-acting antiretrovirals.

Treatment and prevention of HIV infection with long-acting antiretrovirals.

Journal: Expert review of clinical pharmacology
Published: March 30, 2018

Persistently altered liver test results in hepatitis C patients after sustained virological response with direct-acting antivirals.

Persistently altered liver test results in hepatitis C patients after sustained virological response with direct-acting antivirals.

Journal: Journal of viral hepatitis
Published: October 17, 2017

Need to Face Liver Cirrhosis after HCV Cure with Antivirals.

Need to Face Liver Cirrhosis after HCV Cure with Antivirals.

Journal: EBioMedicine
Published: August 25, 2017
Showing 1-12 of 21

Last Updated: 09/26/2026